Drug intelligence / Profile preview

aciclovir cold sore cream

Development stage
Approved
Lead developer
Altova Healthcare
Modality
Small Molecules
Administration
Topical
01

Overview

Aciclovir Cold Sore Cream is a topical antiviral formulation containing 5% aciclovir, developed by Altova Healthcare for the treatment of herpes labialis (cold sores) caused by the herpes simplex virus (HSV). Aciclovir is a synthetic purine nucleoside analogue that selectively inhibits viral DNA replication. Upon entering HSV-infected cells, aciclovir is phosphorylated by viral thymidine kinase to aciclovir monophosphate, which is subsequently converted to the active triphosphate form by host cellular enzymes. Aciclovir triphosphate acts as a competitive inhibitor and substrate for viral DNA polymerase, leading to its incorporation into the growing viral DNA chain and resulting in obligate chain termination. This topical cream is marketed in Australia and other regions to reduce the duration and severity of recurrent cold sores.

Brand names
AcivirBoots Antiviral Cold Sore CreamPinewood Cold Sore CreamVirasorb Cold Sore CreamZoviraxZovirax Cream
Other names
aciclovir 5% creamaciclovir cold sore creamaciclovir creamacyclovir 5% creamacyclovir cream
02

Targets

Herpesvirus DNA polymeraseHSV-TK (Herpes simplex virus type 1 thymidine kinase (HSV1-TK))Human cellular DNA polymeraseDNA polymerase family

Beyond the preview

Go deeper on aciclovir cold sore cream.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aciclovir cold sore cream.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call